High-Dose N -Acetylcysteine in Chronic Obstructive Pulmonary Disease, Prone Positioning in Acute Respiratory Distress Syndrome, and Continuous Positive Airway Pressure and Exhaled Nitric Oxide in Obstructive Sleep Apnea
- 15 January 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 189 (2) , 223-224
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- High-Dose N-Acetylcysteine in Stable COPDChest, 2013
- Long-Term Continuous Positive Airway Pressure Therapy Normalizes High Exhaled Nitric Oxide Levels in Obstructive Sleep ApneaJournal of Clinical Sleep Medicine, 2013
- Prone Positioning in Severe Acute Respiratory Distress SyndromeNew England Journal of Medicine, 2013
- Prone positioning improves survival in severe ARDS: a pathophysiologic review and individual patient meta-analysis.2010
- Prone ventilation reduces mortality in patients with acute respiratory failure and severe hypoxemia: systematic review and meta-analysisIntensive Care Medicine, 2010
- Exhaled breath markers in patients with obstructive sleep apnoeaSleep and Breathing, 2007
- Alveolar-Derived Exhaled Nitric Oxide Is Reduced in Obstructive Sleep Apnea SyndromeChest, 2007
- Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trialThe Lancet, 2005